Results 1 to 5 of 17 in Leeds Institute of Rheumatic and Musculoskeletal Medicine

The Charterhouse Rheumatism Charity (the Charity) was established in 1936 to continue the work of the Charterhouse Rheumatism Clinic.

healthcare professional struggling to communicate with patients whilst wearing full PPE

Patients taking an immunosuppressant drug for rheumatic and musculoskeletal diseases do not appear to be at higher risk of serious outcomes from COVID-19 infection as long as they are vaccinated.

Doctors wearing surgical gowns and masks looking at medical scans

New research has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.

stethoscope, ecg print out

Medication used to treat a range of inflammatory diseases may be less safe than previously thought.

Cardiovascular research at the University of Leeds

Drugs used to treat initial signs of rheumatoid arthritis also improve the early stages of heart disease, according to new research.